Fine Point Consulting, LLC’s Post

Barrigel - symmetry, stability, safety. Customized spacing without time constraints. Because control matters.

Looking forward to the "debate", Kapil Dhingra. Let's see where we all land on balancing a move to increasing our understanding of a patient's particular tumor, with precision of the diagnostics and patient segmentation that implies, versus the advancing of therapeutics that obviate the need for such by their broadness of activity while maintaining a good therapeutic index (like ADCs?), or actually are therapies that are multifunctional to address the heterogeneity and plasticity of the cancer.

We're at the National Cancer Congress Malaysia! 🇲🇾 We're excited to be participating in the National Cancer Congress Malaysia starting today and running until Sunday! Come visit us at booth B9 to learn more about our solutions. Don't miss this opportunity to connect with us and other leading experts in the field! #agtcgenomics #NCCM2024 #sunwayuniversity #CancerGenomics #CancerRiskDx #CancerScreenDx #PreciseDx #LiquidDx #CancerTRACE #Cancercare #ComprehensiveGenomicProfiling

Thrilled to share a pre-print from our National Cancer Institute (NCI)-Washington University in St. Louis collaboration! This study demonstrates that, using fragment characteristics of blood plasma cell free DNA (#cfDNA), we are able to detect not only the aggressive cancer #MPNST (most common cause of premature death in cancer predisposition #neurofibromatosis) but also its #precancer tumor the atypical neurofibroma (AN). This has huge clinical implications: MPNST are treatment resistant sarcoma whose only current treatment is surgery. Because MPNST evolve from within benign tumors in NF1, however, their diagnosis is often delayed and the tumors are frequently inoperable. Interception of their pre-malignant precursor, therefore, would enable early and less morbid curative intervention! We believe that this study serves as a blueprint for #liquibiopsy surveillance in other #cancer predisposition syndromes. #cancerprevention We are incredibly appreciative of Children's Tumor Foundation and Neurofibromatosis Therapeutic Acceleration Program's support that has made this study possible. And, of course, I am beyond grateful to the people with #NF1, their family members, and caregivers who continue to support and inspire this work! Check out our medRxiv pre-print here: https://lnkd.in/eF4Aw4Hv Or, for the Cliffs Notes version, our tweetorial: https://lnkd.in/eiNrE5BK

Cancer screening, cancer diagnosis, cancer treatment and cancer survival should not depend on countries, on postcodes, on maps, on streets, on cities or on any other sides or parts of Europe. The cancer care gap today is UNCONSCIONABLE when the percentage of women who never had a breast cancer screening in Romania is 71 times higher than in Finland. We have to rewrite the story of cancer: equal access, equal chance for every European. 

Sharing this post from the latest work from my friend Monica Marulanda. It is a known fact that early detection saves lives! Cancer screening helps detect abnormalities before symptoms appear, increasing the chances of successful treatment. Routine screenings can detect cancer at its earliest stages when treatment is most effective, emphasizing the need for regular check-ups. But most importantly, access to cancer screening should be equitable, addressing disparities in healthcare access and ensuring all individuals have the opportunity for early detection and treatment. Let's continue to get tested and help raise awareness 💕 #CancerAwareness #EarlyDetectionSavesLives #PersonalizedCare #ScreeningGuidelines #TeamworkForHealth

📣 📆 Only ONE DAY to go to the #canSERV_EU Annual Meeting in Brussels! 🥳 Wednesday, 18th Oct: 🎗️ ▶️ "Perspective on Europe-wide cancer activities & their role in the European Cancer ERA." ▶️ "Sustainability of Europe-wide cancer activities and project." ▶️ Panel discussion on challenges and opportunities. Thursday, 19th Oct, closed Consortium Meeting: ▶️ Work progress in year one, challenges for year two / Work package updates and presentations #canSERV_AM23 #EUCancerMission #EUBeatingCancerPlan

Did you know that April is Head and Neck Cancer Awareness Month? It’s not often I’m in front of the camera but check out this video on Moffitt Cancer Center’s Instagram highlighting the importance and ease of getting screened for head and neck cancer. Incorporating short form video content into our social media strategy has been an effective way to educate our audience and share about upcoming free screening events! #SocialMedia #SocialMediaMarketing #ShortFormVideoContent #CancerAwareness

Save the date 

In Wales, around 1,800 people die from lung cancer every year. We can change this. Our Policy and Public Affairs Manager, Greg Pycroft explains how - https://lnkd.in/ePu-wkn9 Join our call for targeted lung cancer screening in Wales here - https://lnkd.in/df6e4NG8